Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +7 |
| Ticker | PYPD |
| Latest Price | 3.50 USD as of close on 03-Jul-2025 |
| 3 Month price range | 2.43 to 3.74 USD |
| Market Capitalisation | 35.67Mn USD |
| Country | Israel |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. See More ... |
| Company URL | https://www.polypid.com |
| See Darwins Full Analysis for PolyPid Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for PolyPid Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +17 |
| Sentiment | News and Candle Patterns. | +1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
| Flow | Institutional, Fund and Insider buying and selling. | +1 |
| Models | Forecast models. | -14 |
There are 5 live alerts for PolyPid Ltd.
There is 1 peer of PolyPid Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Evogene Ltd (EVGN) | Biotechnology | +20.7 | -12 |
To see complete information on PolyPid Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |